Review



recombinant human icos protein  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems recombinant human icos protein
    Recombinant Human Icos Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+icos+protein/Recombinant+Human+ICOS+Fc+Chimera+Protein%2C+CF/pm41207826-82-50-57
    Average 93 stars, based on 7 article reviews
    recombinant human icos protein - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Red Blood Cell Lysis:

    Article Title: Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils.
    Article Snippet: .. Blood was treated with red blood cell lysis buffer and then incubated for 24 h at 37°C with either recombinant human CD40L protein (rhCD40L, 5 μg/ml; R&D Systems, Minneapolis, MN, USA, 6420-CL-025) or recombinant human ICOS protein (rhICOS, 10 μg/ml; R&D Systems, Minneapolis, MN, USA, 169-CS-050). .. IgG (5 μg/ml; R&D Systems, Minneapolis, MN, USA, 1-001-A) was used as control.

    Article Title: Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils
    Article Snippet: .. Blood was treated with red blood cell lysis buffer and then incubated for 24 h at 37°C with either recombinant human CD40L protein (rhCD40L, 5 μg/ml; R&D Systems, Minneapolis, MN, USA, 6420-CL-025) or recombinant human ICOS protein (rhICOS, 10 μg/ml; R&D Systems, Minneapolis, MN, USA, 169-CS-050). .. IgG (5 μg/ml; R&D Systems, Minneapolis, MN, USA, 1-001-A) was used as control.

    Incubation:

    Article Title: Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils.
    Article Snippet: .. Blood was treated with red blood cell lysis buffer and then incubated for 24 h at 37°C with either recombinant human CD40L protein (rhCD40L, 5 μg/ml; R&D Systems, Minneapolis, MN, USA, 6420-CL-025) or recombinant human ICOS protein (rhICOS, 10 μg/ml; R&D Systems, Minneapolis, MN, USA, 169-CS-050). .. IgG (5 μg/ml; R&D Systems, Minneapolis, MN, USA, 1-001-A) was used as control.

    Article Title: ICOS signaling is involved in the development of allergic rhinitis by regulating the differentiation of T cells, especially Th2 cells.
    Article Snippet: .. PBMC were seeded at a concentration of 1 ×10^6 cells/mL in 24-well plates, with each well containing penicillin/streptomycin (10 μg/ml; Thermo Fisher Scientific, USA, 15140148), CD3/CD28 (5 μg/ml; Biolegend, 422604) and RPMI 1640 medium (Corning, NY, USA, R8758) supplemented with 10 % fetal bovine serum.18 Subsequently, 1 μL of PBS, recombinant human ICOS protein (rh-ICOS; 10 μg/ml; R&D Systems, Minneapolis, MN, USA, 169-CS-050), Pi3k-Akt-mTOR inhibitor (PF04691502; 1 μmol/L, Solarbio, IP2280), and a combination of PF04691502 + rh-ICOS (1 μmol/L + 10 μg/mL) were added to the respective wells, and the cells were incubated at 37 ◦C for 24 h. The PBS-treated group served as the negative control. ..

    Article Title: Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils
    Article Snippet: .. Blood was treated with red blood cell lysis buffer and then incubated for 24 h at 37°C with either recombinant human CD40L protein (rhCD40L, 5 μg/ml; R&D Systems, Minneapolis, MN, USA, 6420-CL-025) or recombinant human ICOS protein (rhICOS, 10 μg/ml; R&D Systems, Minneapolis, MN, USA, 169-CS-050). .. IgG (5 μg/ml; R&D Systems, Minneapolis, MN, USA, 1-001-A) was used as control.

    Recombinant:

    Article Title: Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils.
    Article Snippet: .. Blood was treated with red blood cell lysis buffer and then incubated for 24 h at 37°C with either recombinant human CD40L protein (rhCD40L, 5 μg/ml; R&D Systems, Minneapolis, MN, USA, 6420-CL-025) or recombinant human ICOS protein (rhICOS, 10 μg/ml; R&D Systems, Minneapolis, MN, USA, 169-CS-050). .. IgG (5 μg/ml; R&D Systems, Minneapolis, MN, USA, 1-001-A) was used as control.

    Article Title: ICOS signaling is involved in the development of allergic rhinitis by regulating the differentiation of T cells, especially Th2 cells.
    Article Snippet: .. PBMC were seeded at a concentration of 1 ×10^6 cells/mL in 24-well plates, with each well containing penicillin/streptomycin (10 μg/ml; Thermo Fisher Scientific, USA, 15140148), CD3/CD28 (5 μg/ml; Biolegend, 422604) and RPMI 1640 medium (Corning, NY, USA, R8758) supplemented with 10 % fetal bovine serum.18 Subsequently, 1 μL of PBS, recombinant human ICOS protein (rh-ICOS; 10 μg/ml; R&D Systems, Minneapolis, MN, USA, 169-CS-050), Pi3k-Akt-mTOR inhibitor (PF04691502; 1 μmol/L, Solarbio, IP2280), and a combination of PF04691502 + rh-ICOS (1 μmol/L + 10 μg/mL) were added to the respective wells, and the cells were incubated at 37 ◦C for 24 h. The PBS-treated group served as the negative control. ..

    Article Title: Involvement of CD40-CD40L and ICOS-ICOSL pathways in the development of Chronic Rhinosinusitis by modulating eosinophil function
    Article Snippet: .. 6420-CL-025) or recombinant human ICOS protein (rhICOS, 10ug/ml; R&D systems, Minneapolis, MN, USA, 169-CS-050). .. IgG (5 ug/ml; R&D systems, Minneapolis, MN, USA, 1-001-A) was used as control.

    Article Title: Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils
    Article Snippet: .. Blood was treated with red blood cell lysis buffer and then incubated for 24 h at 37°C with either recombinant human CD40L protein (rhCD40L, 5 μg/ml; R&D Systems, Minneapolis, MN, USA, 6420-CL-025) or recombinant human ICOS protein (rhICOS, 10 μg/ml; R&D Systems, Minneapolis, MN, USA, 169-CS-050). .. IgG (5 μg/ml; R&D Systems, Minneapolis, MN, USA, 1-001-A) was used as control.

    Concentration Assay:

    Article Title: ICOS signaling is involved in the development of allergic rhinitis by regulating the differentiation of T cells, especially Th2 cells.
    Article Snippet: .. PBMC were seeded at a concentration of 1 ×10^6 cells/mL in 24-well plates, with each well containing penicillin/streptomycin (10 μg/ml; Thermo Fisher Scientific, USA, 15140148), CD3/CD28 (5 μg/ml; Biolegend, 422604) and RPMI 1640 medium (Corning, NY, USA, R8758) supplemented with 10 % fetal bovine serum.18 Subsequently, 1 μL of PBS, recombinant human ICOS protein (rh-ICOS; 10 μg/ml; R&D Systems, Minneapolis, MN, USA, 169-CS-050), Pi3k-Akt-mTOR inhibitor (PF04691502; 1 μmol/L, Solarbio, IP2280), and a combination of PF04691502 + rh-ICOS (1 μmol/L + 10 μg/mL) were added to the respective wells, and the cells were incubated at 37 ◦C for 24 h. The PBS-treated group served as the negative control. ..

    Negative Control:

    Article Title: ICOS signaling is involved in the development of allergic rhinitis by regulating the differentiation of T cells, especially Th2 cells.
    Article Snippet: .. PBMC were seeded at a concentration of 1 ×10^6 cells/mL in 24-well plates, with each well containing penicillin/streptomycin (10 μg/ml; Thermo Fisher Scientific, USA, 15140148), CD3/CD28 (5 μg/ml; Biolegend, 422604) and RPMI 1640 medium (Corning, NY, USA, R8758) supplemented with 10 % fetal bovine serum.18 Subsequently, 1 μL of PBS, recombinant human ICOS protein (rh-ICOS; 10 μg/ml; R&D Systems, Minneapolis, MN, USA, 169-CS-050), Pi3k-Akt-mTOR inhibitor (PF04691502; 1 μmol/L, Solarbio, IP2280), and a combination of PF04691502 + rh-ICOS (1 μmol/L + 10 μg/mL) were added to the respective wells, and the cells were incubated at 37 ◦C for 24 h. The PBS-treated group served as the negative control. ..



    Similar Products

    93
    R&D Systems recombinant human icos protein
    Recombinant Human Icos Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+icos+protein/Recombinant+Human+ICOS+Fc+Chimera+Protein%2C+CF/pm41207826-82-50-57
    Average 93 stars, based on 1 article reviews
    recombinant human icos protein - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    Boster Bio icos
    Icos, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+icos+protein/Human+ICOS+Recombinant+Protein/pmc12206865-1-0-4
    Average 94 stars, based on 1 article reviews
    icos - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    R&D Systems human icos
    Human Icos, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+icos+protein/Recombinant+Human+ICOS+Fc+Chimera+Protein%2C+CF/us12326457-298-62-64
    Average 93 stars, based on 1 article reviews
    human icos - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    Boster Bio anti icos
    Anti Icos, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+icos+protein/Human+ICOS+Recombinant+Protein/pmc11662042-63-10-12
    Average 94 stars, based on 1 article reviews
    anti icos - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results